Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cu-medicine-develops-a-probiotic-formula-to-target-imbalance-in-gut-microbiota-in-covid-19
https://www.med.cuhk.edu.hk/press-releases/cu-medicine-develops-a-probiotic-formula-to-target-imbalance-in-gut-microbiota-in-covid-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Have you ever thought about why some people are more vulnerable to catching a virus? And why some get more severe infection than others? Gut microbiota, which is a fine balance between good and bad bacteria, regulates our immune system. Imbalance in gut microbiota (dysbiosis) will make us susceptible to infections.  

 

Before the role of gut microbiota in COVID-19 was identified, the National Health Commission of the People's Republic of China had already included the use of probiotics for treatment of COVID-19 in January 2020. However, currently available probiotic products have many limitations. For example, many probiotic bacteria are susceptible to gastric acid, high temperature and humidity. The shelf-life of many probiotic products is short. On top of that, not all kinds of probiotics can help enhance our immunity. To date, there is an urgent unmet need to define the role of gut microbiota in COVID-19. 

 

The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) is the first to discover a series of good bacteria missing in the gut of COVID-19 patients. The research team confirmed this discovery with a large number of healthy subjects and COVID-19 patients. Using big data analysis and machine learning, the research team has successfully developed a probiotic formula that aims to target gut dysbiosis, thereby offering hope of boosting immunity against COVID-19 and other emerging viral infections. They anticipate that the formula will soon be turned into a probiotic supplement to go with our daily diet to improve our defence against infection.

 

COVID-19

CU Medicine is the first to discover a series of good bacteria missing in the gut of COVID-19 patients. The research team confirmed this discovery with a large number of healthy subjects and COVID-19 patients. Using metagenomics and big data analysis, the research team has successfully developed a probiotic formula that aims to target gut dysbiosis. (From right) Prof. Francis CHAN, Dean of CU Medicine and Director of the Centre for Gut Microbiota Research;  Prof. Paul CHAN, Chairman of the Department of Microbiology; and Prof. Siew NG, Associate Director of the Centre for Gut Microbiota Research at CUHK.

Professor Francis KL CHAN, Dean of CU Medicine and Director of the Centre for Gut Microbiota Research at CUHK, remarked, “Gut health rules over the immune system of our bodies. We must identify the composition of intestinal bacteria that helps maintain our defense. From there on, we can modulate the gut microbiota to boost our immunity against viral and bacterial infections. This will be a novel approach in the combat of COVID-19.”    

 

What is Gut Microbiota?

 

Gut microbiota refers to the microbe population living in our intestine. Our gut microbiota contains tens of trillions of microorganisms, including at least 1,000 different species of known bacteria with more than 3 million genes (150 times more than human genes).  Gut microbiota is as significant to our health as an organ and plays an important role in our immunity. Gut dysbiosis will make us susceptible to infections.  

 

In the latest research published in the international medical journal Gastroenterology,CU Medicine investigated the alteration of gut microbiota in local COVID-19 patients. From February to March this year, stool specimens were collected from 15 COVID-19 patients whose conditions ranged from mild to critically ill from the time of hospitalisation until discharge.  The research team studied the microorganisms present in the patients’ guts and compared them with those from healthy individuals.

 

Professor Paul Kay Sheung CHAN, Chairman of the Department of Microbiology at CU Medicine and Associate Director of the Centre for Gut Microbiota Research at CUHK, said, “This is the first study in the world to realise that severe gut dysbiosis exists in COVID-19 patients.  Some commensal symbionts, generally good bacteria, were missing while other pathogens were increasing in the patients’ guts. The condition prevailed even after patients had been discharged.”

 

prof francis chan

Prof. Francis Chan (left) states that gut health rules over the immune system of our bodies. Through identifying the composition of intestinal bacteria that helps maintain our defence, the gut microbiota can be modulated to boost our immunity against viral and bacterial infections. This will be a novel approach in the combat of COVID-19.

 

prof siew ng

Prof. Siew Ng remarks the CU Medicine’s probiotic formula is derived from gut microbiota data from the Chinese population. The research team is studying good bacteria that are closely linked to human’s immune system with the hope to boost the immunity.

prof paul chan
Prof. Paul Chan says that the recent study of CU Medicine is the first in the world to discover that severe gut dysbiosis exists in COVID-19 patients. Some commensal symbionts, generally good bacteria, were missing while other pathogens were increasing in the patients’ guts.

The research team further expanded the research scope and collected data on gut microbiome of 150 COVID-19 patients and 1,500 healthy individuals. With the use of big data analysis, the team managed to come up with a probiotic formula which targets at gut dysbiosis derived from COVID-19 infections. The CU Medicine team carefully calculated the proportion of good bacteria and came up with a processing protocol which helps enhance the stability and quantity of live bacteria.    

 

Patents Applied for the Innovation and More Researches for Further Scientific Reference

 

Professor Siew Chien NG, Associate Director of the Centre for Gut Microbiota Research at CUHK, explained, “The composition of microorganisms in our gut can be altered by diet or lifestyle.  What appears to be useful in the West may not be as beneficial among Asian populations. This study provides a whole new perspective in the fight against COVID-19. Our probiotic formula is derived from data from the Chinese population. We are studying good bacteria that are closely linked to our immune system and looking for solutions to limit the threat of the novel coronavirus to our health.”

 

COVID-19

The CU Medicine research team anticipates that a probiotic supplement will be produced that could be added into daily diet to enhance the gut health. 

 

CU Medicine has applied for patents for the probiotic innovation in China and the U.S. and is now collaborating with innovation and technology companies and food companies to turn the formula into a probiotic supplement that can be added into the daily diet. The team is hopeful that the innovation can soon reach the public to enhance gut health. They are now working on large-scale clinical trials to provide further scientific evidence on the importance of gut health in preventing any novel infectious diseases. One of the research projects is supported by the Health and Medical Research Fund of the HKSAR government.     

 

More Press Releases

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

Clinical service
CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

Research
CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Awards and honors
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research
CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

Research
CUHK-Designed Intervention Package Proves Effective to Increase Influenza Vaccine Uptake in Hong Kong Young Children

CUHK-Designed Intervention Package Proves Effective to Increase Influenza Vaccine Uptake in Hong Kong Young Children

Research
CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

Health Campaign
CUHK Reveals the Key to a Successful HPV Vaccination Programme

CUHK Reveals the Key to a Successful HPV Vaccination Programme

Research
CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

Education
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

International collaboration
CUHK Proves Rotavirus Vaccine Highly Effective for HK Children

CUHK Proves Rotavirus Vaccine Highly Effective for HK Children

Research
CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

Research
CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

Research
CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

Research
CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

Surgical advancement
CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

Research
CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

Research
CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

Research
CUHK Research Reveals New Influenza Vaccine Offers More Effective Control over Influenza in Hong Kong

CUHK Research Reveals New Influenza Vaccine Offers More Effective Control over Influenza in Hong Kong

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.